Creative Planning Axsome Therapeutics, Inc. Transaction History

Creative Planning

$101 Billion
Q3 2024

A detailed history of Creative Planning transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Creative Planning holds 10,854 shares of AXSM stock, worth $984,783. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,854

Previous 8,365 29.75%

Holding current value

$984,783

Previous $673,000 44.87%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	BUY	$78.93 - $95.84 $196,456 - $238,545	2,489 Added 29.75%	10,854 $975,000
Q2 2024 Aug 15, 2024	BUY	$65.72 - $80.5 $75,512 - $92,494	1,149 Added 15.92%	8,365 $673,000
Q1 2024 May 10, 2024	BUY	$69.39 - $97.64 $25,257 - $35,540	364 Added 5.31%	7,216 $575,000
Q4 2023 Feb 14, 2024	BUY	$57.42 - $83.61 $26,642 - $38,795	464 Added 7.26%	6,852 $545,000
Q3 2023 Nov 16, 2023	BUY	$69.25 - $82.21 $900 - $1,068	13 Added 0.2%	6,388 $446,000
Q2 2023 Jul 21, 2023	SELL	$58.41 - $90.35 $21,670 - $33,519	-371 Reduced 5.5%	6,375 $458,000
Q1 2023 May 15, 2023	SELL	$58.39 - $75.0 $144,164 - $185,175	-2,469 Reduced 26.79%	6,746 $416,000
Q4 2022 Feb 10, 2023	SELL	$39.94 - $79.72 $239 - $478	-6 Reduced 0.07%	9,215 $710,000
Q3 2022 Nov 03, 2022	BUY	$36.06 - $69.85 $332,509 - $644,086	9,221 New	9,221 $411,000
Q3 2021 Nov 10, 2021	SELL	$19.91 - $68.26 $192,489 - $659,937	-9,668 Closed	0 $0
Q2 2021 Aug 04, 2021	SELL	$50.63 - $73.5 $53,313 - $77,395	-1,053 Reduced 9.82%	9,668 $652,000
Q1 2021 Apr 30, 2021	SELL	$55.91 - $81.44 $22,364 - $32,576	-400 Reduced 3.6%	10,721 $607,000
Q4 2020 Jan 29, 2021	SELL	$66.31 - $86.52 $49,997 - $65,236	-754 Reduced 6.35%	11,121 $906,000
Q3 2020 Nov 05, 2020	SELL	$68.34 - $85.84 $421,999 - $530,062	-6,175 Reduced 34.21%	11,875 $846,000
Q2 2020 Jul 23, 2020	BUY	$49.87 - $98.69 $380,208 - $752,412	7,624 Added 73.12%	18,050 $1.49 Million
Q1 2020 May 05, 2020	SELL	$41.2 - $101.31 $160,103 - $393,690	-3,886 Reduced 27.15%	10,426 $613,000
Q4 2019 Jan 30, 2020	BUY	$16.71 - $106.24 $239,153 - $1.52 Million	14,312 New	14,312 $1.48 Million

Others Institutions Holding AXSM

# of Institutions

325

Shares Held

37.7M

Call Options Held

912K

Put Options Held

855K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.89B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Account

Creative Planning Axsome Therapeutics, Inc. Transaction History